TY - JOUR
T1 - Natural History of Functional Gastrointestinal Disorders
T2 - A 12-year Longitudinal Population-Based Study
AU - Halder, Smita L.S.
AU - Locke, G. Richard
AU - Schleck, Cathy D.
AU - Zinsmeister, Alan R.
AU - Melton, L. Joseph
AU - Talley, Nicholas J.
N1 - Funding Information:
Supported in part by grants AGO9440 and AR30582 from the National Institutes of Health, US Public Health Service, and a grant from Novartis Pharmaceuticals.
Funding Information:
Conflicts of Interest: N.J.T. is a consultant for the AGA; Cerebrio; Giaconda Ltd.; Interactive Forums, Inc.; JestaRx Group, Inc.; Johnson & Johnson Pharmaceutical R & D; Medscape from WebMD; Pfizer; Procter & Gamble; Strategic Consultants Intl; and Thervance, Inc and receives financial support from Novartis, Takeda, GlaxoSmithKline, Dynogen, and Tioga. G.R.L. is a consultant for Takeda and receives financial support from Novartis, Boehringer Ingelheim, and TAP.
PY - 2007/9
Y1 - 2007/9
N2 - Background & Aims: Functional gastrointestinal disorders (FGID) are common in the community. The natural history of FGID is unknown because of a lack of prospective population-based studies and the indistinct nature of the phenotype. We sought to report the natural history of FGID in a US population. Methods: This prospective cohort study used data from multiple validated surveys of random samples of Olmsted County, MN, residents over a mean of a 12-year period between 1988 and 2003 (n = 1365). The surveys measured gastrointestinal symptoms experienced during the past year. Each subject received a minimum of 2 surveys. Point prevalence, onset, and disappearance rates and transition probabilities were calculated for individual FGIDs. Results: Between the initial and final surveys, the point prevalences (per 100 residents) were stable for irritable bowel syndrome (8.3% and 11.4%, respectively) and functional dyspepsia (1.9% and 3.3%, respectively). The onset of each of the disorders studied was greater than the disappearance rate, but the transition probabilities varied across the different subgroups. Among people with symptoms at baseline, approximately 20% had the same symptoms, 40% had no symptoms, and 40% had different symptoms at follow-up. Conclusions: Although the prevalence of the FGID was stable over time, the turnover in symptom status was high. Many episodes of symptom disappearance were due to subjects changing symptoms rather than total symptom resolution. This transition between different FGIDs suggests a common etiopathogenesis.
AB - Background & Aims: Functional gastrointestinal disorders (FGID) are common in the community. The natural history of FGID is unknown because of a lack of prospective population-based studies and the indistinct nature of the phenotype. We sought to report the natural history of FGID in a US population. Methods: This prospective cohort study used data from multiple validated surveys of random samples of Olmsted County, MN, residents over a mean of a 12-year period between 1988 and 2003 (n = 1365). The surveys measured gastrointestinal symptoms experienced during the past year. Each subject received a minimum of 2 surveys. Point prevalence, onset, and disappearance rates and transition probabilities were calculated for individual FGIDs. Results: Between the initial and final surveys, the point prevalences (per 100 residents) were stable for irritable bowel syndrome (8.3% and 11.4%, respectively) and functional dyspepsia (1.9% and 3.3%, respectively). The onset of each of the disorders studied was greater than the disappearance rate, but the transition probabilities varied across the different subgroups. Among people with symptoms at baseline, approximately 20% had the same symptoms, 40% had no symptoms, and 40% had different symptoms at follow-up. Conclusions: Although the prevalence of the FGID was stable over time, the turnover in symptom status was high. Many episodes of symptom disappearance were due to subjects changing symptoms rather than total symptom resolution. This transition between different FGIDs suggests a common etiopathogenesis.
UR - http://www.scopus.com/inward/record.url?scp=34548477151&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34548477151&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2007.06.010
DO - 10.1053/j.gastro.2007.06.010
M3 - Article
C2 - 17678917
AN - SCOPUS:34548477151
SN - 0016-5085
VL - 133
SP - 799-807.e1
JO - Gastroenterology
JF - Gastroenterology
IS - 3
ER -